Susquehanna International Group’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $109K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $111K | Buy |
|
|||||
|
2024
Q4 | $35.2K | Buy |
|
|||||
|
2024
Q3 | $22K | Sell |
|
|||||
|
2024
Q2 | $122K | Buy |
|
|||||
|
2024
Q1 | $69.2K | Buy |
|
|||||
|
2023
Q4 | $24.4K | Sell |
|
|||||
|
2023
Q3 | $294K | Buy |
|
|||||
|
2023
Q2 | $80.8K | Buy |
|
|||||
|
2023
Q1 | $65.7K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $263K | Buy |
|
|||||
|
2022
Q2 | $91K | Sell |
|
|||||
|
2022
Q1 | $171K | Sell |
|
|||||
|
2021
Q4 | $356K | Buy |
|
|||||
|
2021
Q3 | $508K | Sell |
|
|||||
|
2021
Q2 | $588K | Sell |
|
|||||
|
2021
Q1 | $1.67M | Buy |
|
|||||
|
2020
Q4 | $491K | Buy |
|